文献速递神经儿科影像MR

利用深度学习预测罕见结节性硬化症相关癫痫儿童抗癫痫药物治疗效果

Predicting Antiseizure Medication Treatment in Children with Rare Tuberous Sclerosis Complex-Related Epilepsy Using Deep Learning.
PubMed 文献 · AJNR Am J Neuroradiol · 2023-01-01

该回顾性研究纳入300例结节性硬化症相关癫痫儿童,分析临床数据及T2WI和FLAIR图像,开发WAE-Net深度学习法预测抗癫痫药物治疗效果。结果显示,发病年龄、成像年龄、婴儿痉挛和抗癫痫药物数量在两种药物治疗结局间有显著差异(P < .05);FLAIR3混合技术能准确定位结节性硬化症病灶,所提方法在测试队列中取得最佳性能(AUC=0.908,准确率0.847)。

要点

  • 发病年龄、成像年龄、婴儿痉挛和抗癫痫药物数量与药物治疗结局显著相关(P < .05)。
  • FLAIR3混合技术(T2WI与FLAIR融合)能准确定位结节性硬化症病灶。
  • WAE-Net深度学习模型在测试队列中预测药物疗效的AUC为0.908,准确率为0.847。

核心结论

  • 所提方法能预测罕见结节性硬化症相关癫痫儿童的抗癫痫药物治疗效果,并可作为未来研究的强基线。

研究设计与样本

  • 回顾性研究,纳入300例结节性硬化症相关癫痫儿童,分析临床数据(性别、发病年龄、成像年龄、婴儿痉挛、抗癫痫药物数量)及T2WI和FLAIR图像。

关键影像表现/征象

  • FLAIR3由T2WI和FLAIR图像组合而成,可增强结节性硬化症病灶与正常脑组织之间的对比度,并能准确定位病灶。

诊断标准与关键数值

  • 所提WAE-Net方法在测试队列中预测抗癫痫药物治疗效果的AUC为0.908,准确率为0.847,在对比方法中表现最佳。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Tuberous sclerosis complex disease is a rare, multisystem genetic disease, but appropriate drug treatment allows many pediatric patients to have positive outcomes. The purpose of this study was to predict the effectiveness of antiseizure medication treatment in children with tuberous sclerosis complex-related epilepsy.

MATERIALS AND METHODS: We conducted a retrospective study involving 300 children with tuberous sclerosis complex-related epilepsy. The study included the analysis of clinical data and T2WI and FLAIR images. The clinical data consisted of sex, age of onset, age at imaging, infantile spasms, and antiseizure medication numbers. To forecast antiseizure medication treatment, we developed a multitechnique deep learning method called WAE-Net. This method used multicontrast MR imaging and clinical data. The T2WI and FLAIR images were combined as FLAIR3 to enhance the contrast between tuberous sclerosis complex lesions and normal brain tissues. We trained a clinical data-based model using a fully connected network with the above-mentioned variables. After that, a weighted-average ensemble network built from the ResNet3D architecture was created as the final model.

RESULTS: The experiments had shown that age of onset, age at imaging, infantile spasms, and antiseizure medication numbers were significantly different between the 2 drug-treatment outcomes (P < .05). The hybrid technique of FLAIR3 could accurately localize tuberous sclerosis complex lesions, and the proposed method achieved the best performance (area under the curve = 0.908 and accuracy of 0.847) in the testing cohort among the compared methods.

CONCLUSIONS: The proposed method could predict antiseizure medication treatment of children with rare tuberous sclerosis complex-related epilepsy and could be a strong baseline for future studies.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Wang H, Hu Z, Jiang D, et al. Predicting Antiseizure Medication Treatment in Children with Rare Tuberous Sclerosis Complex-Related Epilepsy Using Deep Learning. AJNR Am J Neuroradiol. 2023. PMID: 38081677. doi:10.3174/ajnr.A8053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。